These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 36517633)

  • 61. Recent developments of C-4 substituted coumarin derivatives as anticancer agents.
    Dandriyal J; Singla R; Kumar M; Jaitak V
    Eur J Med Chem; 2016 Aug; 119():141-68. PubMed ID: 27155469
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Marcumar [3-(1'-phenylpropyl)-4-hydroxycoumarin]; a new anticoagulant.
    BOURGAIN R; TODD M; HERZIG L; WRIGHT IS
    Circulation; 1954 Nov; 10(5):680-4. PubMed ID: 13209748
    [No Abstract]   [Full Text] [Related]  

  • 63. [The possible tautomeric forms of 4-hydroxycoumarin].
    KLOSA J
    Arch Pharm Ber Dtsch Pharm Ges; 1953; 23(1):37-43. PubMed ID: 13066059
    [No Abstract]   [Full Text] [Related]  

  • 64. Design, Synthesis, and Biological Evaluation of Coumarin-Triazole Hybrid Molecules as Potential Antitumor and Pancreatic Lipase Agents.
    Kahveci B; Yılmaz F; Menteşe E; Ülker S
    Arch Pharm (Weinheim); 2017 Aug; 350(8):. PubMed ID: 28543820
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Intestinal anti-inflammatory activity of coumarin and 4-hydroxycoumarin in the trinitrobenzenesulphonic acid model of rat colitis.
    Luchini AC; Rodrigues-Orsi P; Cestari SH; Seito LN; Witaicenis A; Pellizzon CH; Di Stasi LC
    Biol Pharm Bull; 2008 Jul; 31(7):1343-50. PubMed ID: 18591772
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Clinical data on anticoagulant treatment with 3-(1-phenylpropy1)-4-hydroxycoumarin].
    VERGANI G
    Gazz Med Ital; 1955 Dec; 114(12):269-73. PubMed ID: 13305779
    [No Abstract]   [Full Text] [Related]  

  • 67. [Note on the condensation product between 4-hydroxycoumarin and thionylchloride].
    KLOSA J
    Arch Pharm Ber Dtsch Pharm Ges; 1953; 286(7):348-9. PubMed ID: 13125519
    [No Abstract]   [Full Text] [Related]  

  • 68. DNA-binding activity and cytotoxic and cell-cycle arrest properties of some new coumarin derivatives: a multispectral and computational investigation.
    Khosravifar F; Dehghan G; Bidoki SK; Mahdavi M
    Luminescence; 2020 Feb; 35(1):98-106. PubMed ID: 31475787
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [A new anticoagulant: 3-(1-phenylpropyl)4-hydroxycoumarin; early clinical results].
    VAN WIEN A; VEROFT R
    Acta Clin Belg; 1953; 8(6):618-28. PubMed ID: 13137838
    [No Abstract]   [Full Text] [Related]  

  • 70. [Ambulatory anticoagulant therapy with 3-(l-phenylpropyl)-4-hydroxycoumarin].
    KNOBEL P
    Praxis; 1956 Jan; 45(4):65-72. PubMed ID: 13310434
    [No Abstract]   [Full Text] [Related]  

  • 71. Coumarins: old compounds with novel promising therapeutic perspectives.
    Riveiro ME; De Kimpe N; Moglioni A; Vázquez R; Monczor F; Shayo C; Davio C
    Curr Med Chem; 2010; 17(13):1325-38. PubMed ID: 20166938
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Simple method for the preparation of ketones of 4-hydroxycoumarin with the aid of phosphorus oxychloride].
    KLOSA J
    Arch Pharm Ber Dtsch Pharm Ges; 1955; 288(8-9):356-61. PubMed ID: 13303359
    [No Abstract]   [Full Text] [Related]  

  • 73. Inhibition of zeta-crystallin by Coumarins: a structure-activity study.
    Duhaiman AS
    J Protein Chem; 1996 Apr; 15(3):261-4. PubMed ID: 8804573
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The secretion of 3,3'-ethylidene bis (4-hydroxycoumarin) in milk.
    FANTL P; NELSON JF
    Med J Aust; 1952 Mar; 1(12):404-5. PubMed ID: 14918772
    [No Abstract]   [Full Text] [Related]  

  • 75. [A new assymetrical vitamin K antagonist: 3-(alpha-naphthyl)-4-hydroxycoumarin].
    MORAUX J; MEUNIER P; MENTZER C
    Arch Int Pharmacodyn Ther; 1953 May; 94(1):47-64. PubMed ID: 13066148
    [No Abstract]   [Full Text] [Related]  

  • 76. Water Soluble Coumarin Quaternary Ammonium Chlorides: Synthesis and Biological Evaluation.
    Karataş MO; Noma SAA; Gürses C; Balcıoğlu S; Ateş B; Alıcı B; Çakır Ü
    Chem Biodivers; 2020 Sep; 17(9):e2000258. PubMed ID: 32638471
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Photoprotective effect of coumarin and 3-hydroxycoumarin in sea urchin gametes and embryonic cells.
    de Araujo Leite JC; de Castro TM; Barbosa-Filho JM; de Siqueira-Junior JP; Marques-Santos LF
    J Photochem Photobiol B; 2015 May; 146():44-51. PubMed ID: 25795999
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Ephemeranthol A Suppresses Epithelial to Mesenchymal Transition and FAK-Akt Signaling in Lung Cancer Cells.
    Nonpanya N; Prakhongcheep O; Petsri K; Jitjaicham C; Tungsukruthai S; Sritularak B; Chanvorachote P
    Anticancer Res; 2020 Sep; 40(9):4989-4999. PubMed ID: 32878787
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Bishydroxycoumarin, ethyl biscoumacetate, and 4-hydroxycoumarin anticoagulant No. 63; comparative effects.
    BARKER NW; HANSON HH; MANN FD
    J Am Med Assoc; 1952 Jan; 148(4):274-7. PubMed ID: 14888460
    [No Abstract]   [Full Text] [Related]  

  • 80. Clinical evaluation of acenocoumarin, a new 4-hydroxycoumarin anticoagulant.
    SCHILLING FJ; KRUESI OR
    Am J Med Sci; 1956 May; 231(5):558-63. PubMed ID: 13313541
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.